Erythropoietin is an important drug for the treatment of anemia in hemodialysis patients. But there were many patients with erythropoietin-hyporesponsive. Roxadustat has been shown effective in treating patients with anemia due to chronic kidney disease. However, the efficacy and safety of roxadustat in hemodialysis patients with erythropoietin-hyporesponsive anemia remains unclear.
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
Mic
v0id
null
aaaa
坚强冰枫
DW
古月水兽
xing_xing
aajhajkahna
乐空思
Criminology34
夜月残阳
GingerF
wch666
丹丹
乘11
秋风
学霸业
叽叽
皖公网安备34019202002308
